Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by mmarquison Apr 25, 2002 9:20pm

175 Views

Post# 5048899

RE: NO announcement today

Hanniba1: I'm very new to ONC (see my previous post) but have been a follower of GTG so your post refering to dandak struck a cord. I'm one of those frustrated and disappointed GTG.b longs and can say that board is just nuts sometimes (actually full of nuts!). Good insight into the bash/pump tactics of our friend. I must say that GTG.b, probably due in part to the vehement ex-employees, has more than it's fair share of bashers. I hope this board has a bit more sanity from it's posters. MM

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta